Juliette Murray
NHS Forth Valley(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Estrogen and related hormone effects, Global Cancer Incidence and Screening, Breast Implant and Reconstruction, Breast Lesions and Carcinomas
Most-Cited Works
- → Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer(2008)161 cited
- → Increase in response rate by prolonged treatment with neoadjuvant letrozole(2008)113 cited
- → Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole(2007)107 cited
- → Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole(2006)78 cited
- → A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer(2009)35 cited
- → Short course pre-operative ferrous sulphate supplementation – is it worthwhile in patients with colorectal cancer?(2010)32 cited
- → A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women(2008)29 cited
- → Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer(2013)27 cited
- → Letrozole suppresses plasma oestradiol (E2) levels more completely than anastrozole in postmenopausal women with breast cancer(2006)26 cited
- → Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability(2010)22 cited